Description

BSE notifies listing and trading admission of equity shares issued under ESOP/ESOS schemes by four companies effective October 13, 2025.

Summary

BSE has admitted for trading further securities issued by four companies under their Employee Stock Option Plans (ESOP) and Employee Stock Option Schemes (ESOS). The newly issued equity shares will be available for trading from Monday, October 13, 2025. All listed shares have no lock-in period restrictions.

Key Points

  • Four companies are listing additional equity shares issued under ESOP/ESOS schemes
  • Sai Life Sciences Limited: 150,500 shares (Face Value ₹1)
  • Transport Corporation of India Ltd: 29,630 shares (Face Value ₹2)
  • UTI Asset Management Company Limited: 44,033 shares (Face Value ₹10)
  • Wipro Ltd: 44,401 shares (Face Value ₹2)
  • Trading commences on October 13, 2025
  • No lock-in period applies to any of the listed shares

Regulatory Changes

No regulatory changes introduced. This is a standard listing notification for securities issued under existing ESOP/ESOS frameworks.

Compliance Requirements

Trading members are informed of the new securities availability for trading. No specific compliance actions required beyond normal trading operations.

Important Dates

  • Notice Date: October 10, 2025
  • Trading Commencement: Monday, October 13, 2025

Impact Assessment

Market Impact: Minimal. The addition of these shares represents routine corporate activity related to employee compensation schemes. The volumes are relatively small compared to the companies’ total outstanding shares.

Shareholder Impact: Minor dilution effect for existing shareholders across the four companies. The absence of lock-in periods means these shares are immediately tradable, though ESOP shares are typically held by employees for investment purposes.

Liquidity Impact: Negligible increase in floating stock for these companies, unlikely to materially affect trading liquidity or price discovery.

Impact Justification

Routine listing of ESOP/ESOS shares with no lock-in restrictions; impacts existing shareholders minimally through dilution but is standard corporate activity.